SSGSX | TSLCX | SSGSX / TSLCX | |
Total Expense Ratio | 1.26 | 2.05 | 61% |
Annual Report Gross Expense Ratio | 1.26 | 2.14 | 59% |
Fund Existence | 26 years | 13 years | - |
Gain YTD | -8.400 | -7.333 | 115% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 1000 | 250% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.52B | 78.1M | 7,073% |
Annual Yield % from dividends | 0.52 | 0.00 | - |
Returns for 1 year | -8.36 | -19.81 | 42% |
Returns for 3 years | -3.90 | -29.65 | 13% |
Returns for 5 years | 21.72 | -41.76 | -52% |
Returns for 10 years | 7.10 | -64.46 | -11% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RAGHX | 26.47 | -0.19 | -0.71% |
Virtus KAR Health Sciences A | |||
RWIHX | 68.56 | -0.74 | -1.07% |
American Funds Capital World Gr&Inc R5E | |||
RNTTX | 47.90 | -0.68 | -1.40% |
Russell Inv International Devd Mkts M | |||
MOSAX | 9.41 | -0.15 | -1.57% |
MassMutual Overseas A | |||
JSERX | 51.70 | -0.99 | -1.88% |
JPMorgan Small Cap Equity R5 |